Swiss National Bank’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $273M | Buy |
4,350,600
+290,100
| +7% | +$23.2M | 0.16% | 103 |
|
|
2025
Q4 | $387M | Sell |
4,060,500
-204,200
| -5% | -$20M | 0.23% | 70 |
|
|
2025
Q3 | $416M | Sell |
4,264,700
-212,500
| -5% | -$22M | 0.24% | 69 |
|
|
2025
Q2 | $481M | Buy |
4,477,200
+320,400
| +8% | +$32.4M | 0.29% | 52 |
|
|
2025
Q1 | $419M | Sell |
4,156,800
-3,400
| -0.1% | -$342K | 0.3% | 54 |
|
|
2024
Q4 | $372M | Sell |
4,160,200
-203,400
| -5% | -$17.9M | 0.25% | 66 |
|
|
2024
Q3 | $366M | Buy |
4,363,600
+11,600
| +0.3% | +$914K | 0.24% | 66 |
|
|
2024
Q2 | $335M | Sell |
4,352,000
-35,200
| -0.8% | -$2.58M | 0.23% | 74 |
|
|
2024
Q1 | $300M | Sell |
4,387,200
-191,500
| -4% | -$12.3M | 0.21% | 86 |
|
|
2023
Q4 | $265M | Sell |
4,578,700
-45,600
| -1% | -$2.43M | 0.19% | 94 |
|
|
2023
Q3 | $244M | Sell |
4,624,300
-566,800
| -11% | -$29.7M | 0.19% | 91 |
|
|
2023
Q2 | $281M | Sell |
5,191,100
-493,200
| -9% | -$25.8M | 0.19% | 94 |
|
|
2023
Q1 | $284M | Sell |
5,684,300
-134,100
| -2% | -$6.32M | 0.19% | 95 |
|
|
2022
Q4 | $269M | Sell |
5,818,400
-376,980
| -6% | -$16.3M | 0.19% | 102 |
|
|
2022
Q3 | $240M | Buy |
6,195,380
+6,500
| +0.1% | +$261K | 0.17% | 111 |
|
|
2022
Q2 | $231M | Buy |
6,188,880
+16,900
| +0.3% | +$688K | 0.16% | 121 |
|
|
2022
Q1 | $273M | Buy |
6,171,980
+760,000
| +14% | +$32.9M | 0.15% | 114 |
|
|
2021
Q4 | $230M | Sell |
5,411,980
-211,100
| -4% | -$8.87M | 0.14% | 124 |
|
|
2021
Q3 | $244M | Sell |
5,623,080
-155,500
| -3% | -$6.88M | 0.16% | 115 |
|
|
2021
Q2 | $247M | Buy |
5,778,580
+49,555
| +0.9% | +$2.08M | 0.15% | 119 |
|
|
2021
Q1 | $221M | Buy |
5,729,025
+106,800
| +2% | +$4.04M | 0.15% | 128 |
|
|
2020
Q4 | $202M | Sell |
5,622,225
-145,000
| -3% | -$5.23M | 0.14% | 130 |
|
|
2020
Q3 | $220M | Buy |
5,767,225
+39,300
| +0.7% | +$1.51M | 0.17% | 115 |
|
|
2020
Q2 | $201M | Buy |
5,727,925
+107,600
| +2% | +$3.87M | 0.17% | 118 |
|
|
2020
Q1 | $183M | Buy |
5,620,325
+1,042,500
| +23% | +$40.7M | 0.19% | 105 |
|
|
2019
Q4 | $207M | Sell |
4,577,825
-452,700
| -9% | -$18.9M | 0.21% | 90 |
|
|
2019
Q3 | $205M | Sell |
5,030,525
-36,805
| -0.7% | -$1.56M | 0.22% | 91 |
|
|
2019
Q2 | $218M | Sell |
5,067,330
-129,400
| -2% | -$4.98M | 0.23% | 86 |
|
|
2019
Q1 | $199M | Buy |
5,196,730
+11,400
| +0.2% | +$435K | 0.22% | 93 |
|
|
2018
Q4 | $183M | Buy |
5,185,330
+76,000
| +1% | +$2.76M | 0.24% | 87 |
|
|
2018
Q3 | $197M | Sell |
5,109,330
-159,900
| -3% | -$5.58M | 0.22% | 93 |
|
|
2018
Q2 | $172M | Buy |
5,269,230
+142,200
| +3% | +$4.29M | 0.2% | 106 |
|
|
2018
Q1 | $140M | Sell |
5,127,030
-562,900
| -10% | -$15.3M | 0.17% | 128 |
|
|
2017
Q4 | $141M | Buy |
5,689,930
+31,200
| +0.6% | +$861K | 0.15% | 149 |
|
|
2017
Q3 | $165M | Buy |
5,658,730
+73,800
| +1% | +$2.04M | 0.19% | 117 |
|
|
2017
Q2 | $155M | Buy |
5,584,930
+156,800
| +3% | +$4.16M | 0.18% | 120 |
|
|
2017
Q1 | $135M | Buy |
5,428,130
+1,070,700
| +25% | +$26M | 0.17% | 131 |
|
|
2016
Q4 | $94.3M | Buy |
4,357,430
+602,500
| +16% | +$13.1M | 0.15% | 153 |
|
|
2016
Q3 | $89.4M | Sell |
3,754,930
-24,700
| -0.7% | -$589K | 0.14% | 157 |
|
|
2016
Q2 | $88.3M | Buy |
3,779,630
+284,800
| +8% | +$6.16M | 0.14% | 158 |
|
|
2016
Q1 | $63M | Buy |
3,494,830
+1,053,100
| +43% | +$18.5M | 0.12% | 196 |
|
|
2015
Q4 | $45M | Buy |
2,441,730
+49,400
| +2% | +$885K | 0.11% | 212 |
|
|
2015
Q3 | $39.3M | Buy |
2,392,330
+245,700
| +11% | +$4.2M | 0.1% | 233 |
|
|
2015
Q2 | $38M | Buy |
2,146,630
+125,900
| +6% | +$2.25M | 0.1% | 236 |
|
|
2015
Q1 | $35.9M | Buy |
2,020,730
+788,200
| +64% | +$12.5M | 0.1% | 240 |
|
|
2014
Q4 | $16.3M | Sell |
1,232,530
-35,900
| -3% | -$459K | 0.06% | 316 |
|
|
2014
Q3 | $15M | Sell |
1,268,430
-22,200
| -2% | -$280K | 0.06% | 324 |
|
|
2014
Q2 | $16.5M | Sell |
1,290,630
-3,600
| -0.3% | -$46.8K | 0.06% | 312 |
|
|
2014
Q1 | $17.5M | Sell |
1,294,230
-134,400
| -9% | -$1.76M | 0.07% | 281 |
|
|
2013
Q4 | $17.2M | Sell |
1,428,630
-32,400
| -2% | -$383K | 0.07% | 295 |
|
|
2013
Q3 | $17.2M | Buy |
1,461,030
+16,500
| +1% | +$178K | 0.07% | 287 |
|
|
2013
Q2 | $13.4M | Buy |
+1,444,530
| New | +$12.3M | 0.06% | 335 |
|
Other funds holding BSX
VCM
VPM
Swiss National Bank's BSX Position: Q1 2026 in Review
Swiss National Bank increased its Boston Scientific (BSX) stake by 7.1% in Q1 2026, buying an estimated $23.2M and bringing the position to 4,350,600 shares worth $273M. The position accounts for 0.16% of the portfolio, ranked #103.
Swiss National Bank first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $481M in Q2 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Swiss National Bank held 4,350,600 shares of Boston Scientific worth $273M as of Q1 2026.
- Swiss National Bank bought 290,100 Boston Scientific shares in Q1 2026, an estimated $23.2M.
- Boston Scientific made up 0.16% of Swiss National Bank's portfolio in Q1 2026, its #103 holding.
- Swiss National Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Swiss National Bank's Boston Scientific position peaked at $481M in Q2 2025.
- 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.